ClinicalTrials.gg
RecruitingNCT07627282SPINDATAUpdated Jun 4, 2026

Evaluation of the Evolution of Patient Care Within the Spinal Pathology Department

An interventional study of self-administered questionnaire in Spinal Stenosis, SPINAL Fracture and Vertebral Osteomyelitis, sponsored by University Hospital, Bordeaux. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-04.

Sponsored by University Hospital, Bordeaux · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 2 years 9 months after the study started (first participant enrolled May 2023, registered Mar 2026).
  • Started May 2023; still recruiting 3 years 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
15,000
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Spinal conditions are a major public health issue. Their management by surgical treatment is constantly improving and surgical procedures or implantable medical devices are experiencing significant progress. These innovations have not yet all been precisely evaluated but have already led to significant changes in care practices. The primary objective of our study is to describe, via an exhaustive collection of data, the quarterly evolution over 5 years of practices in the management of spinal pathologies.

Read the detailed description

The team will conduct a monocentric (department of spine surgery, University Hospital of Bordeaux, France) prospective observational study during 5 years, involving all patients treated for a spinal condition (including degenerative pathology of the lumbar, thoracic or cervical spine, deformities of the spine and for the traumatic, infectious and tumor pathologies).The data collected will concern the general condition of the patients, their reasons for consultation, the details of their spinal pathology and its impact using specific functional assessment self-questionnaires, as well as the care provided. A three years follow-up will be planned

02

Conditions studied

  • Spinal Stenosis
  • SPINAL Fracture
  • Vertebral Osteomyelitis
  • Vertebral Metastasis

Keywords

  • spine
  • care
  • surgery
  • evolution
03

In context

Spinal Stenosis

458 studies on the registry are indexed under Spinal Stenosis; 105 are open to participants now.

This study's planned enrollment of 15,000 is above the median of 80 across 281 interventional studies indexed under Spinal Stenosis.

Browse Spinal Stenosis studies →

Lead sponsor

University Hospital, Bordeaux is the lead sponsor of 806 studies on the registry; 197 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient > 18 years old
  • Minor patient, able to accept the data collection, with the consent of the holder(s)
  • Patient consulting for a medical reason involving a spinal pathology in the investigating center (spinal surgery department): Degenerative pathology of the thoracic or lumbar spine; Degenerative pathology of the cervical spine; Deformation of the spine; Urgent traumatic, infectious and tumor pathologies.

Exclusion criteria

Exclusion criteria:

  • Patient under guardianship or curators,
  • Persons deprived of liberty by judicial or administrative decision,
  • Persons undergoing psychiatric treatment under duress requiring the consent of the legal representative
  • Persons unable to express their consent,
  • Persons under legal protection,
  • Patient not affiliated to a social protection scheme.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
15,000 participants (estimated)

Study arms

  • Experimental
    Patient consulting in spine surgery

    quality of life scales for all patient consulting in spine surgery unit and psychological rating scales only for patients who require it (determined by the surgeon)

    Diagnostic Test: self-administered questionnaire

Interventions

  • Diagnostic testself-administered questionnaire

    quality of life scales for all patient consulting in spine surgery unit and psychological rating scales only for patients who require it (determined by the surgeon)

06

What researchers measure

Primary outcomes

  1. Recourse to surgery

    Rate of recourse to surgery by type of spinal pathology given (cervical, thoracic or lumbar degenerative or spinal deformity).

    Time frame: Inclusion visit

Secondary outcomes

  1. Clinical characteristics

    Weight of patient

    Time frame: Inclusion visit, Visit Month 24 and Visit Month 36

  2. Socio-demographic

    Socio-demographic characteristics (occupation)

    Time frame: Inclusion visit, Visit Month 24 and Visit Month 36

  3. Socio-demographic

    Socio-demographic characteristics (sports activities)

    Time frame: Inclusion visit, Visit Month 24 and Visit Month 36

  4. Questionnaire of Quality of life

    Health-related quality of life evaluated using the SF-36 questionnaire. This questionnaire is composed of 11 items and total score from 0 to 100

    Time frame: Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits

  5. Questionnaire of Quality of life

    Health-related quality of life evaluated using the EQ-5D-5L questionnaire. This questionnaire is composed of 5 items and total score from 5 to 25

    Time frame: Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits

  6. Lower back pain.

    The ODI (Oswestry Disability Index) score is used to measure the degree of disability related to lower back pain. The questionnaire contains 10 items, each scored from 0 to 5 points. The maximum total score is 50 points.

    Time frame: Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits

  7. Cervical pain

    The NDI is used to measure disability related to cervical pain via a standardized questionnaire. The questionnaire contains 10 items, each scored from 0 to 5 points. The maximum total score is 50 points. The higher the percentage, the greater the functional impairment.

    Time frame: Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits

  8. Cervical function, Upper limb function, Lower limb function, Bladder function, Quality of life.

    The JOACMEQ (Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire) provides 5 independent scores (0-100): Cervical function, Upper limb function, Lower limb function, Bladder function, Quality of life. Each area gives a score between 0 (worst) and 100 (best condition).

    Time frame: Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits

  9. Evaluation of the safety of care provided.

    For each type of spinal pathology, measurement of: \- Incidence of serious medical complications

    Time frame: Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits

  10. Clinical characteristics

    Body Mass Index of patient

    Time frame: Inclusion visit, Visit Month 24 and Visit Month 36

  11. Evaluation of the safety of care provided.

    For each type of spinal pathology, measurement of Incidence of mortality, assessed by recalling patients lost to follow-up

    Time frame: Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits

  12. Evaluation of the safety of care provided.

    For each type of spinal pathology, measurement of Incidence of surgical site infections

    Time frame: Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits

  13. Evaluation of the safety of care provided.

    For each type of spinal pathology, measurement of Incidence of mechanical complications

    Time frame: Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits

  14. Evaluation of the safety of care provided.

    For each type of spinal pathology, measurement of Incidence of neurological complications

    Time frame: Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits

  15. Evaluation of the safety of care provided.

    For each type of spinal pathology, measurement of Incidence of surgical re-interventions

    Time frame: Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2023 (actual). Primary completion is estimated for Aug 2028, 63 months after the start.

Of 105 non-industry interventional studies with no phase under Spinal Stenosis, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 46. This study's planned 63 months is above that.

Counting every sponsor, half of 123 studies reached it within 30 months; a quarter within 12 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 5, 2026
First posted
Jun 4, 2026
StartActual
May 25, 2023
Primary completionEst.
Aug 2028
CompletionEst.
Aug 2031
Last update
Jun 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07627282
Responsible party
Sponsor
First posted
Jun 4, 2026
Start date
May 25, 2023
Primary completion
Aug 2028 (estimated)
Completion
Aug 2031 (estimated)
Last update
Jun 4, 2026

Study contacts

Benjamin BOUYER, PROF
Contact
b.bouyer@chu-bordeaux.fr
+335 56 79 87 18
Ouidad BEN KACEM
Contact
ouidad.hasnaoui@chu-bordeaux.fr
+335 56 79 87 18 ext. 14 367
Benjamin BOUYER, PROF
principal investigator · University Hospital, Bordeaux

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion